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SUMMARY
Background
The demand for paediatric gastrointestinal (GI) endoscopy has increased,
resulting in a signiﬁcant rise of overall costs.
Aim
To assess the clinical impact of the Rome II criteria for functional gastro-
intestinal disorders when selecting paediatric patients who underwent GI
endoscopy.
Methods
The indications and ﬁndings of GI endoscopic procedures performed
before and after the publication of the Rome II criteria were evaluated
retrospectively.
Results
Upper GI endoscopy was performed in 1124 children, whereas colonoscopy
was performed in 500 subjects. A total of 607 (54%) oesophago-gastro-
duodenoscopies (OGDs) were positive and 517 (46%) were negative,
whereas 306 (61.1%) colonoscopies were positive and 194 (38.9%) were
negative. Of the 1624 procedures, 26% were considered inappropriate
according to the Rome II criteria. Inappropriate procedures decreased sig-
niﬁcantly after publication of the Rome II criteria (OR, 3.7; 95% CI, 1.8–
7.5). Of 1202 appropriate GI endoscopies, 502 OGD (62.7%) were signiﬁ-
cantly contributive, compared with only 105 (32.5%) of the 323 inappropri-
ate procedures (OR, 3.5; 95% CI, 2.6–4.6), whereas 265 (65.8%)
colonoscopies were signiﬁcantly contributive, compared with only 41
(42.3%) of the 97 inappropriate procedures (OR, 2.6; 95% CI, 1.6–4.1).
Conclusions
The use of the criteria for functional gastrointestinal disorders makes a sig-
niﬁcant positive impact, they should reduce unnecessary paediatric GI
endoscopy.
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INTRODUCTION
Functional gastrointestinal disorders (FGIDs) are deﬁned
as a variable combination of chronic or recurrent gastro-
intestinal symptoms unexplained by structural or bio-
chemical abnormalities. In 1997, a paediatric working
team met in Rome to standardize the diagnostic criteria
for various FGIDs in children. The ﬁrst paediatric crite-
ria for FGIDs were published in 1999 as the Rome II cri-
teria.1 These criteria were created as a diagnostic tool
and as a way to advance empirical research, providing
clinicians with a positive approach to treating paediatric
patients. Recently, in light of emerging scientiﬁc research
and on the basis of clinical experience, the Rome II pae-
diatric criteria have been updated and revised. The Rome
III paediatric criteria represent an evolution from Rome
II and should prove useful for both clinicians and
researchers dealing with childhood FGIDs.2, 3
The demand for gastrointestinal endoscopy has
increased in most developed countries, resulting in a sig-
niﬁcant rise in overall costs for endoscopic procedures.4
During the past few years, various organizations have
tried to develop criteria for selecting patients most likely
to beneﬁt from gastrointestinal endoscopy.5 Ofﬁcial rec-
ommendations on the appropriate use of endoscopy in
adults have been released.6, 7 Although few studies have
compared the efﬁciency of gastrointestinal endoscopy to
other diagnostic procedures in paediatric patients, rec-
ommendations were issued in 1996 by the North Ameri-
can Society of Pediatric Gastoenterology, Hepatology and
Nutrition (NASPGHAN).8 In addition, a technical report
by NASPGHAN concluded that, in the evaluation of
chronic abdominal pain ‘there is little evidence to sug-
gest that use of endoscopy and biopsy in the absence
of alarm symptoms has a signiﬁcant yield of organic
disease’.9
Adult studies suggest, however, that alarm features
may not discriminate functional from organic disease.10
There are few studies examining the diagnostic outcomes
of gastrointestinal endoscopy in children.11 The diagnostic
yield of oesophago-gastro-duodenoscopy (OGD) in chil-
dren with abdominal pain was 3.6% in the existing litera-
ture, but this data were based on studies which were
compromised by small simple size, variable ﬁndings,
selection bias and the use of not standardized diagnostic
criteria.11 None of the studies used the Rome II paediatric
criteria for functional abdominal pain. Few of them exam-
ined the predictive value of blood work obtained prior to
endoscopy and none of them analysed the association of
alarm symptoms or signs to diagnostic yield.11 To our
knowledge, there are no studies evaluating appropriate-
ness and diagnostic yield of colonoscopy in the manage-
ment of children with gastrointestinal disorders.
The main purpose of this study was to assess the
impact of the Rome II paediatric criteria for FGIDs in
selecting paediatric patients who underwent upper or
lower gastrointestinal endoscopy. The secondary objec-
tives were to evaluate the association of alarm symptoms
or signs to diagnostic yield and the predictive value of
blood work obtained prior to endoscopy.
PATIENTS AND METHODS
The study was a retrospective, single-centre, cross-sec-
tional study of 1624 consecutive children who underwent
upper or lower GI endoscopy at the Department of Pedi-
atrics of the University of Naples ‘Federico II’ from Janu-
ary 1998 to December 2006. To avoid repeated measures
from patients with multiple examinations during the
study period, only the patients’ ﬁrst procedure was eligi-
ble for the study. No patient was excluded on the
grounds of having a concomitant chronic disease.
A chart review was performed on all patients who
met inclusion criteria. Procedure note, pathology report,
laboratory reports, and history and physical examination
performed up to 1 month prior to the procedure were
considered. For those patients who lacked a qualifying
history and physical examination, ICD9 codes were
reviewed in the electronic medical record. Clinical infor-
mation was collected prior to the procedure information
to mask the reviewer to the outcome of the endoscopy.
A review of laboratory tests, which had been obtained up
to 1 month prior to the procedure, included haemoglo-
bin level, erythrocyte sedimentation rate (ESR), C-reac-
tive protein (CRP), albumin and faecal calprotectin.
Alarm symptoms or signs were evaluated included invol-
untary weight loss, deceleration of linear growth, gastro-
intestinal blood loss, vomiting, chronic severe diarrhoea,
persistent right upper or right lower quadrant pain.12
Chronic diarrhoea was deﬁned as the passage of three or
more watery stool per day for at least 2 weeks.13
The decision to perform endoscopy was made by the
hospital-based paediatric gastroenterologist who evalu-
ated symptoms reported by the parents or family and
applied the Rome II paediatric diagnostic criteria after
their publication.
Endoscopic examination was carried out using stan-
dard, forward-viewing pediatric Olympus endoscopes
(Europe GMBH, Hamburg, Germany) by experienced
paediatric gastroenterologists (EM, AS). The upper or
lower GI endoscopies were performed in either an
endoscopy room or an operating room. Those patients
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who underwent the procedure in an endoscopy room
were sedated, while those in the operating room were
put under general anaesthesia. The decision between
these two modalities was based on patient age, reason
for endoscopy, and medical history. Sedation, when used,
consisted of midazolam, administered intravenously
(0.1 mg ⁄kg). During the colonoscopy, three biopsies were
taken from the ileum and subsequently a minimum of
two biopsies was taken from every segment of the colon.
In the case of an OGD, biopsies were taken from the
duodenum, anthrum, corpus and oesophagus.
Endoscopic ﬁndings were reported according to inter-
nationally accepted terms and deﬁnitions whenever pos-
sible. Review of the ﬁnal pathology report provided the
data source for histological diagnosis. Endoscopic proce-
dures were considered positive if they had direct impact
on treatment (i.e. gross abnormalities, clinically relevant
biopsy ﬁndings such as coeliac disease and inﬂammatory
bowel disease). They were considered negative if their
ﬁndings were normal or showed abnormalities that did
not affect treatment, such as non-speciﬁc endoscopic
ﬁndings (e.g. erythema, increase or loss vascularity and
pallor) and descriptive histological changes (e.g. reactive
changes, oedema, mild inﬂammatory changes).14, 15
Based on the symptoms, endoscopic procedures were
considered inappropriate if the Rome criteria had been
met and appropriate if they had not been met. Two
investigators (EG and AT), who were unaware of the
endoscopic ﬁndings judged the appropriateness of the
indication of the endoscopic ﬁndings, according to
the Rome II paediatric criteria. To evaluate the effect of
the Rome II paediatric criteria on practices, indications
and ﬁndings of GI endoscopic procedures, performed
before the publication of the FGIDs, diagnostic criteria
were compared with those procedures performed under
them.1 The Rome II diagnostic criteria are summarized
in Table S1.
Means and medians were calculated for dimensional
variables after controlling for normality of distribution.
The Student’s t test for normally distributed variables
and the Mann–Whitney U-test and chi-square test and
Fisher exact tests for categorical variables were used
where appropriate.
Logistic regression analysis has been used to estimate
the probability of positive events occurring in upper as
well as lower GI endoscopy. The probability of the event
occurring was obtained by the linear combination of the
contribution of the following indicator variables which
signiﬁcantly contributed, positively as well as negatively,
to the prediction of the event: deceleration of linear
growth, gastrointestinal blood loss, signiﬁcant vomiting,
persistent right upper or right lower quadrant pain invol-
untary weight loss, chronic severe diarrhoea. The sign of
the regression coefﬁcient suggests positive or negative
contribution: the coefﬁcient can be interpreted as the
change in the log odds associated with one-unit in the
independent variables. A forward stepwise selection was
adopted. Odds ratio and accompanying 95% C.I. were
calculated using maximum likelihood ratio method.
Statistical analysis was carried out using SPSS statistical
software package for Windows (13.0, SPSS Inc., Chicago,
IL, USA). The study was approved by the Institutional
Review Board of the University of Naples ‘Federico II’.
RESULTS
During the study period, 1916 GI endoscopic procedures
were performed in 1713 patients of which 292 were
excluded. Ninety-six were excluded because of repeated
endoscopies, 136 because they had undergone incomplete
procedures, and 60 were excluded because their data
were incomplete. Thus, this study was based on 1624
procedures, each performed in an individual patient. The
patients’ mean age was 7.4 years (range: 2 months–
18 years; 732 boys and 892 girls). OGD was performed
in 1124 children, whereas colonoscopy was performed in
500 subjects. A total of 269 (23%) upper GI endoscopies
and 64 colonoscopies (12.8%) were performed before the
September 1999 publication of the Rome II criteria in
Gut.1 Table 1 details the indications or symptoms for
which endoscopy was performed. A total of 607 (54%)
OGDs were positive and 517 (46%) were negative (155
with normal appearance, and 362 with non-speciﬁc
endoscopic ﬁndings), whereas 306 (61.1%) colonoscopies
were positive and 194 (38.9%) were negative (46 with
normal appearance and 152 with non-speciﬁc endosoco-
pic ﬁndings). Diagnoses of the upper and lower GI
endoscopies are reported in the Table 2.
Gender and age were not predictors of diagnostic
yield OR = 1, 95% CI, 0.8–1.3, v2 = 0.2, P = 0.33;
OR = 1.2, 95% CI, 0.9–1.5, v2 = 0.4, P = 0.54) (Table 3).
Patients with one or more alarm symptoms who
underwent OGD did not have signiﬁcantly better diag-
nostic yield than those without (53.4% vs. 56.6%,
P = 0.43). All patients who underwent colonoscopy had
at least one alarm symptom. Among alarm symptoms,
deceleration of linear growth was associated with
increased diagnostic yield of OGD (OR, 2.5; 95% CI,
1.7–3.7; v2 = 21.1; P = 0.0001), whereas gastrointestinal
blood loss, vomiting, chronic severe diarrhoea and
persistent right upper or lower quadrant pain were
E. Miele et al.
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signiﬁcantly associated with a negative diagnostic yield of
OGD (OR, 0.2; 95% CI, 0.1–0.3; v2 = 45, P = 0.0001;
OR, 0.5; 95% CI, 0.4–0.7; v2 = 26, P = 0.0001; OR, 0.3;
95% CI, 0.2–0.5; v2 = 33, P = 0.001; OR, 0.7; 95% CI,
0.6–0.9; v2 = 6.6, P = 0.01, respectively) (Table 4). As
regards colonoscopy weight loss, deceleration of linear
growth, gastrointestinal blood loss, chronic severe diar-
rhoea and persistent right upper or lower quadrant pain
resulted signiﬁcantly associated with increased diagnostic
yield (OR, 8.4; 95% CI, 5.1–14; v2 = 82, P = 0.0001; OR,
2; 95% CI, 1.1–3.5; v2 = 6.7, P = 0.01; OR, 2.5; 95% CI,
1.5–4; v2 = 16, P = 0.0001; OR, 4.6; 95% CI, 3–7;
v2 = 63, P = 0.001; OR, 5.5; 95% CI, 3.6–8.6; v2 = 64,
P = 0.01 respectively).
Laboratory parameters including haematocrit, albu-
min, ESR, CRP and faecal calprotectin were not predic-
tive of diagnostic yield of OGD (v2 = 0.09, P = 0.4;
v2 = 0.04, P = 0.5; v2 = 0.003, P = 0.5; v2 = 0.2, P = 0.3;
v2 = 0.3, P = 0.3). However, we found a predictive value
of the diagnostic yield of colonoscopy for haematocrit,
CRP and of faecal calprotectin (v2 = 34, P = 0.02;
v2 = 65, P = 0.001; v2 = 56, P = 0.007).
Of the 1624 procedures, 26% were considered inap-
propriate according to the Rome II paediatric criteria.
Kappa coefﬁcient between the two investigators resulted
0.91 (95% CI: 0.88–0.93; agreement: 0.97; SE: 0.01).
A total of 420 children satisﬁed the Rome II criteria
for the various FGIDs (Table S2). The number of inap-
propriate procedures as a percentage of the total number
of procedures performed decreased signiﬁcantly (from
38% to 14%) after publication of the Rome II paediatric
criteria (OR, 3.7; 95% CI, 1.8–7.5; P < 0.001). The proba-
bility of ﬁnding a clinically relevant lesion was signiﬁ-
cantly higher in appropriate endoscopies compared with
those that were inappropriate according to the Rome II
paediatric criteria. Of 1202 appropriate upper or lower
GI endoscopies (801 OGD; 500 colonoscopies), 502
OGD (62.7%) were signiﬁcantly contributive, compared
with only 105 (32.5%) of the 323 inappropriate proce-
dures (OR, 3.5; 95% CI, 2.6–4.6; P < 0.001), whereas 265
(65.8%) colonoscopies were signiﬁcantly contributive,
compared with only 41 (42.3%) of the 97 inappropriate
procedures (OR, 2.6; 95% CI, 1.6–4.1; P < 0.001).
After the publication of the Rome II paediatric crite-
ria, the proportion of upper GI endoscopy performed for
coeliac disease was signiﬁcantly higher than that before
the publication of the criteria (42.9% vs. 21.4%; v2 = 123;
P = 0.00001); no signiﬁcant difference was observed in
the proportion of the procedures performed for peptic
ulcer disease (21.7% vs. 20.6%; v2 = 0.18; P = 0.6);
whereas a signiﬁcant decrease in the proportion of nega-
tive upper GI endoscopy was found (56.8% vs.
36.4%;v2 = 44.9; P = 0.00001). A signiﬁcant increase in
the proportion of lower GI endoscopy for inﬂammatory
bowel disease (IBD) was observed when performed
under the Rome II paediatric criteria (22.9% vs. 63.9%;
v2 = 38; P = 0.00001). Because of the difference in distri-
bution, we also found a signiﬁcant decrease in the
Table 1 | Indications or symp-
toms for upper and lower gas-
trointestinal endoscopy
Before Rome II
criteria
After Rome II
criteria All subjects*
n. 333 n. 1291 n. 1624
N (%) N (%) N (%)
Failure to thrive 36 (10.8) 121 (9.3) 157 (9.6)
Unexplained weight loss 92 (27.6) 392 (30.3) 484 (29.8)
Dysphagia 74 (22.2) 266 (20.6) 340 (20.9)
Recurrent abdominal pain 236 (70.8) 572 (44.3) 808 (49.7)
Vomiting ⁄Regurgitation 132 (39.6) 189 (14.6) 321 (19.7)
Bleeding from GI tract 99 (29.7) 436 (33.7) 535 (32.9)
Chronic diarrhoea 88 (26.4) 323 (25.1) 411 (25.3)
Anaemia 32 (9.6) 152 (11.7) 184 (11.3)
Suspected oesophageal varices 19 (5.7) 78 (6.0) 97 (5.8)
Coeliac disease 30 (9) 376 (29.1) 406 (25)
* More than one indication or symptom was reported in some subjects.
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proportion of lower endoscopy performed for GI polyps
(18.5 vs. 7.3%; v2 = 7.68; P = 0.051), as well as a signiﬁ-
cant decrease in the proportion of negative colonoscopies
(58.5% vs. 28.7%; v2 = 20; P = 0.00006).
To determine which alarm symptoms were signiﬁcant
predictors of diagnostic yield exploratory multivariate
conditional logistic regression was conducted in SPSS.
Data were screened for predictors as involuntary weight
loss, deceleration of linear growth, gastrointestinal blood
loss, vomiting, chronic severe diarrhoea, persistent right
upper or right lower quadrant pain. Deceleration of the
linear growth was independently correlated with an
increased diagnostic yield of OGD, while vomiting, gastro-
intestinal blood loss (haematemesis, haematochezia,
occult lower GI bleeding) and persistent right upper or
right lower quadrant pain predicted a negative diagnostic
yield of OGD. As regards colonoscopy, involuntary
weight loss, chronic diarrhoea, persistent right upper or
right lower quadrant pain and gastrointestinal blood loss
(haematochezia, occult lower GI bleeding) remained
independently associated with an increased diagnostic
yield (Table 5).
DISCUSSION
Gastrointestinal endoscopy is an essential tool for the
evaluation of gastrointestinal disorders in children.
Upper and lower endoscopic procedures may be useful if
the physician suspects organic pathology, such as inﬂam-
matory bowel disease, allergic ⁄ eosinophilic gastrointesti-
nal disease or peptic ulcer disease. These disorders may
also present with additional alarm symptoms or signs
such as involuntary weight loss, growth failure, gastroin-
testinal bleeding, chronic diarrhoea, unexplained fever,
vomiting, or family history of inﬂammatory bowel dis-
ease.9 A recent systematic review demonstrated that the
diagnostic yield of OGD in children with unexplained
Table 3 | Clinical characteristics of children undergone
upper and lower GI endoscopy
Appropriate Inappropriate
Oesophago-gastro-duodenoscopy
Subjects 801 323
Mean age (years, range) 6.7 (0 to18) 7.5 (0 to18)
Gender
Male 318 120
Female 483 203
Positive 501 106
Negative 299 218
Colonoscopy
Subjects 403 97
Mean age (years, range) 10.3 (2 to18) 10.2 (2 to 18)
Gender
Male 206 50
Female 197 47
Positive 265 41
Negative 138 56
Table 2 | Diagnoses and appropriateness according to
the Rome II criteria of upper and lower gastrointestinal
endoscopy
Oesophago-gastro-duodenoscopy
Subjects Appropriate Inappropriate
n. 607 (%) n. 504 (83) n. 103 (17)
Coeliac disease 325 (53.5) 301 (92.6) 24 (7.4)
Reflux oesophagitis 157 (25.9) 109 (69.4) 48 (31.6)
Helicobacter
pylori infection
83 (13.7) 61 (73.5) 22 (26.5)
Eosinophilic
oesophagitis
25 (4.1) 18 (72) 7 (28)
Focal gastritis or
duodenal
inflammation
12 (2) 9 (75) 3 (25)
Crohn’s disease 5 (0.8) 4 (80) 1 (20)
Colonoscopy
Subjects Appropriate Inappropriate
n. 306 (%) n. 265 (86.6) n. 41 (13.4)
Inflammatory bowel
disease
133 (43.4) 122 (91.7) 11 (8.3)
Ulcerative colitis 71 (53.4)
Crohn’s disease 53 (39.8)
Indeterminate
colitis
9 (6.8)
Polyps 40 (13) 34 (85) 6 (15)
Allergic colitis 30 (9.8) 25 (83.3) 5 (16.7)
Infectious 6 (2) 6 (100) 0 (0)
Lymphonodular
hyperplasia
39 (13) 32 (82.1) 7 (17.9)
Eosinophilic colitis 18 (5.8) 15 (83.3) 3 (16.7)
Focal colitis 40 (13) 31 (77.5) 9 (22.5)
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abdominal pain is low; however existing studies are
insufﬁcient. The effect of OGD on change in treatment,
quality of life, improvement of abdominal pain and cost-
effectiveness is unknown. The predictors of signiﬁcant
ﬁndings are unclear.11
A retrospective study suggested that colonoscopy is
the investigative method of choice in children with pro-
longed rectal bleeding. In patients presenting with
accompanying complaints such as abdominal pain or
diarrhoea, it is advisable to perform ileocolonoscopy
combined with OGD. This combines a high diagnostic
yield with a safe procedure.16
Standardized symptom-based criteria were introduced
in 1999 with the publication of the Rome II criteria for
FGIDs in children.1 Since their publication, the Rome II
criteria have been used to assess the prevalence of FGIDs
in community settings17, 18 and have served as selection
criteria in laboratory studies of paediatric FGIDs.19 Sev-
eral empirical studies have used the Rome II criteria to
estimate the rates of various FGIDs among children with
primary symptoms of abdominal pain.20–22
To our knowledge, this is the ﬁrst study examining
the appropriate use of upper and lower gastrointestinal
endoscopy in children using the Rome II paediatric crite-
ria.1 A retrospective design was used as one of our objec-
tives was to compare the periods before and after
publication of the Rome II paediatric criteria and this is
why we did not apply the Rome III criteria published in
2006.2 A potential source of error inherent in the retro-
spective design of this study could be that some of the
patients included may have had symptoms that were not
recorded in the medical charts.
Table 4 | Diagnostic yield of upper and lower gastrointestinal endoscopy for alarm symptoms*8
Upper GI endoscopy Colonoscopy
Positive (%) Negative (%) P Positive (%) Negative (%) P
Subjects
Any alarm symptom
Present 491 (80.9) 428 (83) 0.43 222 (72.7) 385 (26.3) NA
Absent 116 (19.1) 89 (17)
Weight loss
Present 164 (27) 143 (27.6) 0.73 153 (50) 21 (10.8) 0.0001
Absent 443 (73) 374 (72.4) 153 (50) 173 (89.2)
Deceleration of linear growth
Present 96 (15.8) 36 (7) 0.0001 52 (17) 19 (10) 0.01
Absent 511 (84.2) 481 (93) 254 (83) 175 (90)
Gastrointestinal blood loss
Present 29 (4.8) 89 (17.2) 0.0001 267 (87.5) 150 (77.7) 0.0001
Absent 578 (95.2) 428 (82.8) 39 (12.5) 44 (22.3)
Significant vomiting
Present 164 (27) 214 (41.4) 0.0001
Absent 443 (73) 303 (58.6)
Chronic severe diarrhoea
Present 38 (6.3) 89 (17.2) 0.0001 216 (70.8) 68 (22.2) 0.001
Absent 569 (93.7) 428 (82.8) 90 (29.2) 238 (77.8)
Persistent right upper or right lower quadrant pain
Present 308 (50.8) 302 (58.6) 0.01 267 (87.5) 107 (55.5) 0.0001
Absent 299 (49.2) 215 (41.4) 39 (12.5) 87 (44.5)
* More than one finding was reported in some subjects.
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In this study, the overall yield was 54% for OGD and
61.1% for colonoscopy, similar to what others have
found in paediatric and adult series, with coeliac disease
(53.3%), reﬂux oesophagitis (25.9%), H. pylori infection
(13.7%) and inﬂammatory bowel disease (43.4%) being
the most frequent ﬁndings.23–25
After the Rome II paediatric criteria were instituted,
the proportion of OGDs performed for coeliac disease
signiﬁcantly increased and the presentation has changed.
According to the previous studies, an increasingly large
proportion of children are presenting with nongastroin-
testinal symptoms, with almost one in four children
being diagnosed by targeted screening.26
According to a previous paediatric study, IBD was the
most common cause in children referred for colonoscopy
both before and after the institution of Rome II paediat-
ric criteria.16 This ﬁnding conﬁrms the rise in incidence
of IBD in childhood.27
The probability of the endoscopic detection of a clini-
cally relevant ﬁnding was higher in those examinations
judged as appropriate compared with those deemed
inappropriate, according to the Rome II paediatric crite-
ria. However, the low speciﬁcity of the Rome II criteria
could be indicated by the presence of patients who
underwent an appropriate procedure that resulted in a
negative ﬁnding, as well as by the presence of those
patients who underwent an inappropriate endoscopic
procedure that resulted in a positive ﬁnding.1 By com-
paring endoscopic procedures performed before the pub-
lication of the diagnostic criteria with those procedures
performed after its publication, we found that the Rome
criteria signiﬁcantly reduced the proportion of negative
endoscopies. Nevertheless, the value of a negative endos-
copy should not be overlooked, as it can inﬂuence the
subsequent management of the patients, and allows
unnecessary therapies to be excluded. In a previous
study, 67% of the negative endoscopies in adult patients
were judged to have inﬂuenced patient management.28
The mean number of GI endoscopies was 166.5 per
year before the publication of Rome II criteria, while it
increased to 236 per year after the publication of the
diagnostic criteria. This data could be explained by sev-
eral factors. The higher number of procedures could be
attributed to an increased visibility of our GI endoscopy
centre. However, the number of inappropriate endoscop-
ies signiﬁcantly decreased, according to the hypothesis
that primary care physicians may be using Rome II pae-
diatric criteria to ﬁlter their referrals. During the study
period, no systemic ⁄procedural changes occurred that
may have resulted in improved appropriateness of endos-
copy over time, except from experience of paediatric
gastroenterologists.
The role of alarm symptoms in predicting endoscopic
ﬁndings is still controversial. Alarm symptoms are tradi-
tionally thought to be associated with organic disease.10
A technical report by the American Academy of Pediat-
rics and NASPGHAN suggested that alarm symptoms
should be used to screen children for endoscopy (Evi-
dence D).9 By contrast, Ashorn and Maki noted that
endoscopic abnormalities in their patients did not corre-
late with the symptoms associated with chronic abdomi-
nal pain.29 In addition, a recent study by Thakkar et al.
found that several alarm symptoms other than vomiting
were not signiﬁcantly predictive of diagnostic yield.30 In
our cohort, alarm symptoms (apart from deceleration of
linear growth) were predictive of decreased diagnostic
yield. On the basis of these results, alarm symptoms
seem to be inaccurate and should not be used for decid-
ing who to select for OGD among paediatric patients
with upper GI symptoms. However, our retrospective
study has the potential for recall bias that may result in
overestimation of the prevalence of ‘alarm’ symptoms
prior to endoscopy. The situation regarding lower gastro-
intestinal pathology appears more promising.10, 16 In
addition, laboratory parameters including haematocrit,
albumin, ESR, C-reactive protein (CRP) and faecal cal-
protectin were not predictive of OGD diagnostic yield,
whereas a predictive value of ESR, CRP and faecal cal-
protectin has been observed for colonoscopy in the pre-
vious paediatric studies.31–33
Table 5 | Potential predictors associated with diagnostic
yield of OGD and colonoscopy in a multivariate analysis
Regression
coefficient
Odds
ratio 95% CI
OGD
Deceleration of linear growth 0.17 1.24 1.16–1.32
Gastrointestinal blood loss )0.15 0.85 0.78–0.93
Significant vomiting )0.07 0.93 0.89–0.96
Persistent right upper or
right lower quadrant pain
)0.09 0.9 0.82–0.95
Colonoscopy
Involuntary weight loss 0.27 1.21 1.13–1.3
Gastrointestinal blood loss 0.16 1.2 1.11–1.3
Chronic severe diarrhoea 0.22 1.19 1.13–1.27
Persistent right upper or right
lower quadrant pain and
0.2 1.28 1.2–1.37
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In conclusion, this is the ﬁrst paediatric, retrospec-
tive, observational study, evaluating the impact of the
Rome II paediatric criteria on the appropriateness of
GI endoscopy. The study ﬁnds that the use of the crite-
ria for FGIDs makes a signiﬁcant positive impact in
reducing unnecessary GI endoscopic procedures,
improving the diagnostic yield and the cost-effectiveness
of paediatric endoscopy. However, further reﬁnement
and clariﬁcation of the Rome paediatric criteria may be
needed to improve diagnostic agreement. Further steps
are required to update and standardize the guidelines
for gastrointestinal paediatric endoscopy and to pro-
mote educational programmes for paediatric gastroente-
rologists.
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